SEC Form 4 · accession 0001181431-15-000537

DAVITA INC. · DVA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael David Staffieri

Officer — COO, Kidney Care

Period of report

Jan 2, 2014

Accepted (ET)

Jan 6, 2015 · 7:35 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000927066

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jan 2, 2015	M	17,000	$31.70	A	17,000	D
Common Stock	Jan 2, 2015	F	7,116	$75.74	D	9,884	D
Common Stock^F2	Jan 2, 2015	S	9,884	$75.5242	D	0	D
Common Stock	Jan 2, 2015	M	80,000	$34.515	A	80,000	D
Common Stock	Jan 2, 2015	F	36,457	$75.74	D	43,543	D
Common Stock^F3	Jan 2, 2015	S	43,543	$75.8282	D	0	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Appreciation Rights^F4	$31.70	Jan 2, 2015	M	17,000	D	Mar 31, 2012	Mar 31, 2015	Common Stock	17,000	0	D
Stock Appreciation Rights^F5	$34.515	Jan 2, 2015	M	80,000	D	Sep 30, 2011	Sep 30, 2015	Common Stock	80,000	40,000	D

Explanation of responses

F1The sales reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2014.
F2Represents the weighted average sale price of $75.5242. The range of prices for the sale of these shares was $75.47 - $75.60, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F3Represents the weighted average sale price of $75.8282. The range of prices for the sale of these shares was $75.60 - $76.31, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
F4Stock Appreciation Rights, granted on 3/31/10, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 33.3% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.
F5Stock Appreciation Rights, granted on 9/30/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.